BGPT: Paper Review: Strongyloides stercoralis prevalence and diagnostic efficacy of an IgG4 rapid test in an eosinophilic population in Khuzestan Province, southwestern Iran

Explore by Goal

Quick Answer Copied

Skeptical take (what the data most strongly support)

In an eosinophilic referral population in Khuzestan (n=520), the paper reports seroprevalence of Strongyloides using ELISA (35.2%) and a prototype IgG4 lateral-flow RDT (43.7%), with substantial serology agreement (κ=0.776; ρ=0.772).
Against a traditional coprological reference (TCR; “at least one positive coprological test”), the IgG4 RDT is reported as very high sensitivity (100%) but moderate specificity (73.4%), while the agar plate culture (APC) shows the highest coprology AUC (reported as 0.986 under TCR analysis).
Biggest scientific caution: the study uses composite reference standards (CRS) to address lack of a gold standard, but CRS composition choices can shift specificity/sensitivity estimates; follow-up is limited (n=30) and stool sampling is incomplete (146/520 did not provide stool).

Long Answer

Paper Review (rigorous, skeptical, evidence-grounded)

Title: Strongyloides stercoralis prevalence and diagnostic efficacy of an IgG4 rapid test in an eosinophilic population in Khuzestan Province, southwestern Iran.

Study type: Cross-sectional + subset follow-up

1) Visualize the key numerical claims first

Seroprevalence in eosinophilic participants (n=520)

Counts are taken directly from the manuscript abstract/results summary: ELISA positive 183/520 (35.2%), IgG4 RDT positive 227/520 (43.7%), combined seropositive 233/520 (44.8%).

Coprology positivity among stool submitters (n=373)

The manuscript reports DS positive 28/373 (7.5%) and APC positive 93/373 (24.9%); total copro-positive 95.

Diagnostic performance trade-off (TCR reference): Sensitivity vs Specificity

These values are from the manuscript’s diagnostic performance table under the traditional coprological reference (TCR) (n=373).

2) Evidence-based critique: what is strong vs what is fragile

2.1 What is well-supported by the presented data

High internal consistency within serology: the paper reports substantial concordance between IgG4 RDT and ELISA (κ=0.776; Spearman ρ=0.772; P<0.001).
Coprology comparison is explicit: APC detects substantially more positives than DS (24.9% vs 7.5% among stool submitters), consistent with the stated methodological sensitivity differences.
Follow-up signals antibody/eosinophil dynamics in the subset (n=30): eosinophil measures decrease significantly after treatment, and serological readouts tend to drop.

2.2 Fragilities / potential sources of bias (must be treated as uncertainty)

No universal gold standard is a known problem in strongyloidiasis diagnostics; the paper uses composite reference standards (CRS) to compensate.
Verification bias via missing stool samples: 146/520 did not provide stool, so coprology-based outcomes and reference-dependent performance estimates apply to a subset (n=373 for many coprology analyses).
Coprology uses single-sample logic: larvae excretion is intermittent; DS is low sensitivity and culture sensitivity may still depend on number of samples.
Antibody tests are not a direct measure of active infection: serology can remain positive after treatment (imperfectly aligned with current larval output). The paper’s own follow-up shows persistent positives in some individuals.
Treatment choice and dosing uncertainty for follow-up interpretation: authors used albendazole (region’s only anti-Strongyloides medication stated) and limited follow-up, so antibody/loss of eosinophilia may not perfectly reflect microbiologic cure.

3) How to interpret the headline claim (diagnostic efficacy)

3.1 What seems to be happening mechanistically (grounded in data, not fantasy)

The IgG4 RDT reports higher sensitivity than ELISA under TCR, but lower specificity (73.4% vs 82.7%).
This pattern is consistent with a test that may capture more low-burden or earlier/changing immune responses that coprology fails to detect—but in absence of a true gold standard, it is impossible to know whether “extra positives” are true infections or antibody persistence/cross-reactivity.

3.2 A crucial meta-issue: AUC depends on reference definition

The paper reports AUCs that differ under TCR vs CRS (e.g., ELISA AUC 0.908 vs 0.975; IgG4 RDT AUC 0.867 vs 0.938). Such shifts are expected when the “positive” definition changes.

4) Reproducibility-critical table (extracted numerics)

Reference	Test	Sensitivity (%)	Specificity (%)	PPV	NPV	Kappa
TCR	IgG4 RDT	100	73.4	56.2	100	0.584
TCR	ELISA	98.9	82.7	66.2	99.6	0.702
TCR	DS	29.5	100	100	80.57	0.384
TCR	APC	97.9	100	100	99.28	0.986
CRS	IgG4 RDT	98.5	89	84.1	99	0.845
CRS	ELISA	92.8	99.1	98.4	95.8	0.929
CRS	DS	9.2	100	100	65.8	0.224
CRS	APC	63.7	100	100	81.1	0.681

Table values are directly taken from the paper’s diagnostic performance table (TCR: n=373 stool submitters; CRS: n=520).

5) What would most disprove/alter the paper’s practical claim?

A large external validation in populations where “eosinophilic referral” is absent, using a rigorous target-condition-aligned reference standard, where the IgG4 RDT maintains high sensitivity and improves specificity substantially relative to ELISA.
Demonstrating that false positives under TCR are due to antibody persistence (rather than active infection or cross-reactivity) would change how one defines “usefulness” for screening—yet the follow-up subset here is limited (n=30).

6) Author-review shortcuts (BGPT)

Feedback:

Updated: July 12, 2026